The US brachytherapy market is anticipated to grow at a substantial significant CAGR during the forecast period. The market was valued at $347.4 million in 2020. The US is the major market of brachytherapy due to various factors such as investments in R&D, high healthcare expenditure, the presence of key players, and the rising prevalence of cancer patients. The high prevalence of cancer has contributed to the growth of the US brachytherapy market. According to the American Cancer Society in 2019, around 1.8 million new cases were recorded and 891,480 people died in the US due to cancer, around 200,500 would be caused by cigarette smoking. According to the American Cancer Society in 2019, 85% of all cancers in the US were diagnosed in people of age group 50 and above.

The US brachytherapy market is segmented based on indication and type. Based on indication, the brachytherapy market is segmented into breast cancer, gynecological cancer, prostate cancer, skin cancer, brain cancer, and others. Prostate cancer held a major share in the region as according to the American Cancer Society, 1 in 9 men are likely to be diagnosed with prostate cancer during their lifetime. While 1 in 39 men dies with this disease. Based on type, the brachytherapy market is segmented into LDR and HDR.

Some of the major companies serving the US brachytherapy market include AngioDynamics, Inc., General Electric Co., Hologic, Inc., Isoray, Inc., Sensus Healthcare, Inc., Sun Nuclear Corp., and others. The market players are considerably contributing to the market growth by adopting various strategies including mergers and acquisitions, collaborations, to stay competitive in the market. 

Additionally, various organizations are involved in the R&D of brachytherapy and its application in different cancers. For instance, the UCLA Brachytherapy Division is one of the most experienced and advanced centers in the US that have expertise in using brachytherapy to treat all types of cancers. The center has state-of-the-art equipment and facilities including a brachytherapy suite in the Department of Radiation Oncology, a portable CT scanner for imaging during implants, real-time ultrasound planning for prostate brachytherapy, a new Flexitron afterloader, and a Xoft unit for intraoperative breast radiation.

Research Methodology

The market study of the US brachytherapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report is intended for brachytherapy market player, medical device manufacturer, healthcare service providers, institutional investors, and other end-user for overall market analysis, and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation

1. US Brachytherapy Market Research and Analysis by Indication
2. US Brachytherapy Market Research and Analysis by Type

The Report Covers

• Comprehensive research methodology of the US brachytherapy market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US brachytherapy market.
• Insights about market determinants that are stimulating the US brachytherapy market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.